#pharmaceutical-innovation
#pharmaceutical-innovation

[ follow ]

Researching lizard poison led to Ozempic. It's the kind of breakthrough that science funding cuts could end

The discovery of GLP-1 drugs showcases how foundational research can lead to significant medical innovations for diabetes treatment.

FDA approves non-opioid painkiller designed to eliminate risk of addiction

Vertex has received FDA approval for Journavx, a pain medication designed to mitigate addiction and overdose risks typically associated with opioids.

Dutch-based Alveron Pharma raises 5M to advance therapy for intracranial haemorrhage - Silicon Canals

Alveron Pharma secured €5M funding to advance OKL-1111, a drug designed to treat intracranial haemorrhage and improve patient outcomes.

FDA approves non-opioid painkiller designed to eliminate risk of addiction

Vertex has received FDA approval for Journavx, a pain medication designed to mitigate addiction and overdose risks typically associated with opioids.

Dutch-based Alveron Pharma raises 5M to advance therapy for intracranial haemorrhage - Silicon Canals

Alveron Pharma secured €5M funding to advance OKL-1111, a drug designed to treat intracranial haemorrhage and improve patient outcomes.

Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year

Isomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.

Glucose-sensitive insulin with attenuation of hypoglycaemia - Nature

The quest for glucose-responsive insulin seeks to prevent hypoglycaemia while maintaining optimal glucose control.

Engineering glucose-responsive properties in insulin itself offers a promising alternative to existing methods for diabetes management.

I'm the Danish scientist who pioneered injectable drugs like Ozempic. Here are my 3 tips for inventing blockbuster products.

Lotte Bjerre Knudsen's research was pivotal in transforming short-acting GLP-1 hormones into successful long-acting diabetes treatments like Ozempic.

Glucose-sensitive insulin with attenuation of hypoglycaemia - Nature

The quest for glucose-responsive insulin seeks to prevent hypoglycaemia while maintaining optimal glucose control.

Engineering glucose-responsive properties in insulin itself offers a promising alternative to existing methods for diabetes management.

I'm the Danish scientist who pioneered injectable drugs like Ozempic. Here are my 3 tips for inventing blockbuster products.

Lotte Bjerre Knudsen's research was pivotal in transforming short-acting GLP-1 hormones into successful long-acting diabetes treatments like Ozempic.

Sanofi CEO Paul Hudson takes inspiration from 'Fight Club' to get his team hooked on AI

Sanofi is integrating AI across its value chain, highlighting its commitment to innovation during a recent hackathon led by CEO Paul Hudson.

What Alicia Boler Davis had to 'unlearn' from Jeff Bezos and Amazon to lead digital pharmacy Alto

Alicia Boler Davis transitioned from Amazon to Alto to leverage her skills and impact the antiquated pharmacy industry.

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Eli Lilly's stock has experienced significant growth, indicating strong market confidence and potential for future stock splits.

Investors should focus on projected revenue and innovations rather than solely on past performance when evaluating Eli Lilly's future.

[ Load more ]